Ethyl 3-methyl-2-thioxo-2,3-dihydro-1H-imidazole-1-carboxylate

Catalog No. :
ACRTVD361
CAS No. :
22232-54-8
Molecular Formula :
C7H10N2O2S
Molecular Weight :
186.24

IUPAC Name:ethyl 3-methyl-2-thioxo-2,3-dihydro-1H-imidazole-1-carboxylate

Ethyl 3-methyl-2-thioxo-2,3-dihydro-1H-imidazole-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$57.00Login to see priceIn stockInquiry
100g97%$206.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 3-methyl-2-thioxo-2,3-dihydro-1H-imidazole-1-carboxylate
IUPAC Nameethyl 3-methyl-2-thioxo-2,3-dihydro-1H-imidazole-1-carboxylate
MDL No.MFCD00027421
Molecular FormulaC7H10N2O2S
Molecular Weight186.24
SMILESO=C(N1C=CN(C)C1=S)OCC
InChI KeyCFOYWRHIYXMDOT-UHFFFAOYSA-N
SynonymEN300-7816879 | NCGC00177988-02 | Tox21_302320 | TYRAZOL | Mertiran | Tox21_110596_1 | A16427 | AS-13267 | Carbimazol (INN-Spanish, French) | NCGC00095167-02 | 3-METHYL-2-THIOI-MIDAZOLINE-1-CARBOXYLATE | Epitope ID:116890 | Carbimazolum (INN-Latin) | HY-B
CAS No.22232-54-8
PubChem CID31072

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACRTVD361 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBCQJ097 route compound structure diagram
    ACBCQJ09760-56-0 In Stock
  4. Then
  5. ACRTVD361 route product structure diagram
    ACRTVD36122232-54-8 In Stock
Inquiry

2. ACRTVD361 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRTVD361 route product structure diagram
    ACRTVD36122232-54-8 In Stock
Inquiry

Comments (0)